Page last updated: 2024-11-02

pentamidine and Metabolic Diseases

pentamidine has been researched along with Metabolic Diseases in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortés, E1
Jufresa, J1
Falcó, V1
Ribera, E1

Other Studies

1 other study available for pentamidine and Metabolic Diseases

ArticleYear
[Hypocalcemia and hypomagnesemia associated with the treatment with pentamidine in 2 patients with HIV infection].
    Medicina clinica, 1996, May-11, Volume: 106, Issue:18

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Humans; Hypocalcemia; Magnesium; Male;

1996